Mar 28, 2011, 08.55 PM | Source: CNBC-TV18
Greenstone, the generic arm of pharmaceutical major Pfizer has voluntarily recalled two drugs on account of mislabeling reports CNBC-TV18's Ekta Batra.
Ekta Batra (more)
Markets Anchor & Financial Analyst, CNBC-TV18 |
"Around 500 bottles of Finasteride (a drug used to treat prostatic hyperplasia, a non-cancerous prostate enlargement) have been labelled as Citalopram (an anti-depressant)," sources close to the development said.
Aurobindo Pharma supplies these formulations to Pfizer. However, the source of the lapse is yet unknown—weather the mislabeling has happened on the pharmacy level or at Aurobindo's end.
At 11:43 am Aurobindo was quoting at Rs 189.85, down Rs 8, or 4.04%. However, Pfizer continued to quote higher at Rs 1,214.70, up Rs 22.75, or 1.91%.
More from the block: Natco Pharma to sell US pharma biz when opportunity knocks
Justice Rajiv Sahai Endlaw also sought an explanat
"The Board of Directors of the company has appoint
Pfizer Ltd has informed BSE that the Board of Dire
Justice Rajiv Sahai Endlaw granted the interim rel
US markets recovered from day's low to end flat on